Robért K H, Einhorn S, Ostlund L, Juliusson G, Biberfeld P
Hematol Oncol. 1986 Apr-Jun;4(2):113-20. doi: 10.1002/hon.2900040203.
3H-thymidine incorporation following stimulation with interferon (IFN) in vitro was investigated in cell cultures from peripheral blood of patients with chronic lymphocytic leukemia (CLL), spleens from necro-kidney transplants and healthy blood donors. It was demonstrated, that IFN can induce a proliferative response in some normal as well as leukemic B lymphocyte subsets. The responses were not T-cell dependent. The results indicate, that B-cell subsets that proliferate in the presence of IFN, are present in higher proportions in spleen than in peripheral blood, and that they constitute a portion of the leukemic blood lymphocyte pool in some patients with CLL. We have previously demonstrated, that IFN induces varying degrees of transformation and differentiation in blood lymphocytes from a majority of CLL patients. The functional characteristics of different B-cell subsets, and their heterogeneous distribution in leukemia, may be important for the results of IFN treatment in various malignant B-cell disorders.
在慢性淋巴细胞白血病(CLL)患者外周血的细胞培养物、坏死性肾移植脾脏以及健康献血者中,研究了体外干扰素(IFN)刺激后的3H-胸腺嘧啶核苷掺入情况。结果表明,IFN可在一些正常以及白血病B淋巴细胞亚群中诱导增殖反应。这些反应不依赖T细胞。结果表明,在IFN存在下增殖的B细胞亚群在脾脏中的比例高于外周血,并且它们构成了一些CLL患者白血病血淋巴细胞池的一部分。我们之前已经证明,IFN可在大多数CLL患者的血淋巴细胞中诱导不同程度的转化和分化。不同B细胞亚群的功能特征及其在白血病中的异质性分布,可能对各种恶性B细胞疾病的IFN治疗结果具有重要意义。